The American Cancer Society Cancer Action Network (ACS CAN) is launching a new print and digital ad campaign today emphasizing the dangerous impact that proposed changes to Medicare Part D’s six protected classes could have on patients’ access to affordable drug therapies.
Access to Affordable Cancer Drugs Press Releases
Cancer Patients in Medicare Could Face Cost and Care Barriers Under Proposal to Alter ‘Six Protected Classes’
The Department of Health and Human Services announced proposed changes to the Medicare Part C and D regulations today that if finalized could dramatically impact access to affordable medication and quality care for cancer patients on the program. The administration is proposing to alter rules around Medicare Part D’s “Six Protected Classes.” The proposals could have cost, care and safety implications.
On Friday, October 26, ACS CAN will host its annual policy forum in Oregon. This year's event focuses on the pressing issues surrounding the cost of breast cancer across different types of insurance.
Allowing Step Therapy in Medicare Part B Could Erect Barriers to Care for Cancer for Cancer Patients
The Center for Medicare and Medicaid Services (CMS) issued guidance last night giving Medicare Advantage plans the option of applying step therapy for physician-administered and other Part B drugs, effective January 1, 2019.
Today the American Cancer Society Cancer Action Network submitted comments to the Department of Health and Human Services (HHS) regarding proposals to reduce prescription drug costs outlined in the administration’s Request for Information (RFI) regarding its Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs (blueprint).
Proposals expected to be announced as part of the administration's American Patients First plan, include various changes to Medicare’s prescription drug program, such as protecting beneficiaries from catastrophic costs through an out-of-pocket maximum, and requiring plans to share a minimum portion of drug rebates with patients.